Endo Int'l (ENDP) Tops Q3 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Endo Reports Third Quarter 2016 Financial Results
November 8, 2016 6:30 AM ESTDUBLIN, Nov. 8, 2016 /PRNewswire/ --
Third quarter 2016 reported revenues of $884 million and diluted GAAP loss per share from continuing operations of $0.86 Third quarter 2016 adjusted diluted earnings per share (EPS) of $1.01 Company Reaffirms Full Year 2016 Revenues and Adjusted Diluted EPS Financial GuidanceEndo International plc (NASDAQ: ENDP) (TSX: ENL) today reported third quarter 2016 financial results, including:
Revenues of $884 million including the addition of sales from its 2015 acquisition of Par Pharmaceutical, a 19 percent increase... More